Tags : Continued Access Studies

Avita Medical Reports Results of RECELL System in Investigational Device

Tuba Khan April 8, 2019

Shots: The IDE compassionate use and continued access studies involve assessing of Spray-On Skin Cells prepared using the RECELL system + meshed autografts in 107 pediatric patients with deep burn […]readmore

Tags : Continued Access Studies

Avita Medical Reports Results of RECELL System in Investigational Device

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Continued Access Studies

﻿Avita Medical Reports Results of RECELL System in Investigational Device

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

Avita Medical Reports Results of RECELL System in Investigational Device